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Abstract 
Soluble protein expression is a key requirement for biochemical and structural biology 
approaches to study biological systems in vitro. Production of sufficient quantities may not 
always be achievable if proteins are poorly soluble which is frequently determined by 
physico-chemical parameters such as intrinsic disorder. It is well known that discrete protein 
domains often have a greater likelihood of high-level soluble expression and crystallizability. 
Determination of such protein domain boundaries can be challenging for novel proteins. Here 
we outline the application of bioinformatics tools to facilitate the prediction of potential 
protein domain boundaries, which can then be used in designing expression construct 
boundaries for parallelized screening in a range of heterologous expression systems. 
 
Key words: Bioinformatics, Protein expression, Protein solubility, Protein structure, Domain, 
BLAST, PSIPRED, Hidden Markov Model (HMM), Alignment, Secondary structure. 
 
1 Introduction 
In order to study proteins by structural, biochemical or biophysical approaches, a key 
requirement is the ability to produce sufficient levels of purified protein, ranging from the 
microgram to milligram levels depending on the technique in question [1]. It is costly, 
inefficient and often impossible to obtain sufficiently pure and adequate quantities from 
native sources [2]. Modern approaches frequently utilize heterologous protein expression 
systems such as Escherichia coli, optimized to produce large quantities of protein from 
plasmid expression vectors containing a cloned and defined sequence [3, 4]. It is well known, 
however, that sequence of the protein is one of the most important determinants of successful 
protein expression, solubility or crystallization potential [1, 5]. Results vary greatly between 
the expression constructs used (encoding fragments of defined protein sequence length and 
context) [6] due to differing protein physicochemical properties and biological factors such as 
protein folding, export or toxicity in the host cell. Indeed, studies on heterologous expression 
in E. coli show that less than half of proteins from prokaryotes and one fifth from eukaryotes 
can be expressed in a soluble form as full-length proteins [7]. 
 
In such circumstances researchers often turn to alternative expression hosts, often closer to 
the original organism of the protein of interest [8], such as other bacterial systems (e.g., 
Bacillus [9] and Lactococcus [10]), or eukaryotic systems (e.g., baculovirus/insect cells [11] 
and protozoa [12]). Furthermore, a wide range of solubility-enhancing and affinity fusion tags 
have also been successfully applied to heterologous expression systems, such as GST, MBP 
and thioredoxin [13]. Different levels of expression between fusion tags and target proteins in 
comparative screens however suggest the necessity of screening multiple tags [14]. 
 
Eukaryotic proteins are often comprised of modular structures of defined, folded domains, 
linked by flexible or unstructured stretches of sequence. Protein domains are thought to fold 
independently, exhibit globularity (e.g., contain a hydrophobic core and hydrophilic exterior) 
and perform a specific function (e.g., binding), such that the combination and juxtapositioning 
of domains determines overall protein function [15]. There is a long-held premise that well-
ordered or compact domains or fragments will yield better-behaving proteins than full-length 
proteins for protein expression and structural studies, in relation to solubility and 
crystallization potential [7]. For instance, rigid proteins have a greater propensity to 
crystallize than flexible or highly disordered proteins [5], resulting from increased flexibility 
either between domains in multi-domain proteins, or from within domains (e.g.. unstructured 
N- or C-termini or internal loops) entropically hampering crystallization [16]. Furthermore, 
many proteins exist in complexes with other partners, exhibiting poor expression or solubility 
when expressed alone and/or in alternative hosts due to, for example, the exposing of 
hydrophobic patches that the interacting partner normally protects [17]. This may occur even 
if such regions are localized to a single domain. 
 
Therefore, delineation of independent, folded and compact protein domains for expression as 
individual units is a key tool in protein and structural biochemistry. Significant attempts have 
been undertaken to predict optimal protein constructs for expression, many of which involve 
multiple truncations of full-length proteins from either, or both, the N- and C-termini to 
express individual domains [7]. Parallel analysis of multiple domains and domain fragments 
has been simplified with the advent of high-throughput cloning and expression/purification 
methods [18]. Iterative but random trial and error approaches towards construct N- or C-
terminal truncation however can be costly and time-consuming. 
 
A more informed approach, which we call ‘domain boundary analysis’ or DBA, involves the 
interrogation of multiple bioinformatics methods to predict protein structural features. This 
targeted approach to delimit protein domain boundaries and their subsequent combinatorial 
arrangement is more likely to result in ordered, defined and globular protein fragments [6, 
19]. DBA has been very successful in our hands, with nearly half of human proteins 
attempted being successfully expressed and purified, and around 20 % of those attempted 
resulting in a solved high-resolution X-ray structure [1]. Here we take the reader through 
practical usage of a range of common bioinformatics approaches used in DBA, towards 
defining well-behaving protein domains for biochemical and structural analysis. 
 
2 Materials 
All analyses described here can be performed on any standard PC, Mac OS X or Linux-based 
operating system on a standard desktop or laptop computer with an internet connection. Most 
common web browsers (Explorer, Safari, Chrome etc.) work with the bioinformatics servers 
described. Many of the platforms described can be downloaded and installed locally on 
Linux-based systems or incorporated into bespoke web services, but we are restricting our 
descriptions to individual web-based analyses for ease of use. The sole requirement from the 
user is the protein sequence of interest, with residues represented in the IUPAC single letter 
code format [20]. In a minority of cases, it may be necessary to provide the sequence in 
FASTA format [21] which can be facilitated by the simple addition of an identifier (name) 
preceded with the character “>”, required as the first and separate line in the sequence: 
 
>sequence_name 
MTGHYTHHAYGRETYIPSDFGNMKILPSSWQ 
 
Protein three-dimensional structure visualization can be performed also using web-based 
software or via software that is either provided specifically for an operating system (e.g., 
Windows, OS/X, Linux) or in an independent form using a platform such as Java. 
 
3 Methods 
Our approach to defining construct boundaries by DBA utilizes a range of common 
bioinformatics approaches, all freely available online. A hierarchical approach is taken to 
define boundaries (Fig. 1), initially identifying domains using a combination of homology-
based and Hidden Markov Model (HMM) approaches, supplemented by disorder prediction 
to suggest protein globularity, a reliable indicator of folded domains. Once potential domains 
are identified, multiple finer-grained boundaries are defined using predicted secondary 
structural elements as termini, again supplemented with disorder propensity information. 
Sequence and structural homology information can further supplement to help guide the 
determination of likely soluble or crystallizable protein boundaries. 
 
[Fig 1 near here] 
 
Parallel testing of multiple constructs with different domain boundaries can increase 
experimental success (Fig. 2). [1]. Our DBA approach is designed to be used in conjunction 
with Ligation-Independent Cloning (LIC) or other high-throughput cloning methods to 
construct N- and C-terminal tagged fusions, combined with small-scale parallel expression in 
multiple systems (E. coli, baculovirus-infected insect cells) [1, 7, 18, 22]. The number of 
domain boundaries attempted is determined by the researcher in relation to resources and time 
available but, from our experience, 12-40 constructs per domain is typical, normally matched 
to multiple domain-defining secondary structural elements [1]. If multiple tandem domains 
are present, the respective N- and C-terminal boundaries can also be combined for multiple-
domain constructs (Fig. 2). In addition, it is also worth attempting the full-length protein itself 
in expression trials, perhaps with multiple small N- and C-terminal DBA-defined truncations. 
 
[Fig 2 near here] 
 
3.1 Prediction of Protein Secondary Structure and Domains using Sequence and Structural 
Homology 
Since the concept of the “domain hypothesis”, a number of experimental and de novo 
computational/statistical methods have been used to attempt to predict protein domain 
boundaries [15]. The simplest approach to assign boundaries however, is often by similarity 
to previously defined domains. Hence, the approach we take for DBA uses a number of 
complementary approaches, either based on direct sequence-based homology (BLAST [23], 
Conserved Domain Database (CDD) [24]), or profile HMM-based approaches (SMART [25], 
PFAM [26]). The CDD is a database of annotated multiple sequence alignments, allowing 
alignment of query sequences to previously detected or characterized domains. The HMM-
based SMART and PFAM databases provide a complementary, but often more sensitive, 
detection of domains including many not found in the CDD, alongside a number of predicted 
but uncharacterized “Domains of Unknown Function” (DUFs). These approaches are 
particularly useful to identify “core” domain regions, the precise boundaries of which can be 
subsequently explored with disorder/secondary element prediction tools described later. 
 
Where strong sequence homology to existing characterized domains may not exist, predicted 
secondary structure (PSIPRED [27]) and homologies both to close (BLAST/Protein Data 
Bank (PDB) [28]) and remote structural templates (pGenTHREADER [29]) can potentially 
be identified, to guide construct termini design. 
 
3.1.1 Domain Prediction using Homology Searching: BLAST and the CDD 
1. Navigate to the NCBI BLAST server web interface 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) [23]. 
2. Select the “protein blast” program, in the Basic BLAST section to open the standard 
BLAST interface to the blastp algorithm. 
3. Copy and paste the full-length query sequence in FASTA or simple text sequence format 
(or the NCBI protein accession code) into the query box, or select “Choose File” and 
navigate to the respective file, if the sequence is saved as a text file (see Note 1). 
4. Select the database to be searched from the dropdown menu of the Database option of the 
Choose Search Set section. Choose “Protein Data Bank proteins (pdb)” to search within 
potential homologous structures (see Note 2). 
5. The BLAST search can be optionally taxonomically limited should the user require, by 
starting to type either the common or Latin species/taxon name into the Organism field 
(e.g., Homo sapiens). On typing, taxon options pop up, and select the most relevant one 
(see Note 3). 
6. Leave the algorithm and general parameters as default for blastp (protein-protein 
BLAST), with BLOSUM62 matrix and gap parameters as 11/1 (see Note 4). 
7. Press the blue “BLAST” button to run the search. 
8. Once the search is complete, the results are graphically displayed as an overview 
distribution of BLAST hits mapped onto the query sequence (Fig. 3a). The color 
represents the homology between query sequence and identified sequence, with red 
matches as closest and the longest significant match at the top of the matched sequences 
(color key is above at the top of the distribution image). Multiple matched regions 
represent the presence of multiple domains in the query sequence. 
9. Select a match on the distribution image to automatically scroll down the page to 
respective alignment HSP report (Fig. 3b), representing a homologous sequence for 
which a protein structure is present in the PDB database (see Note 5). The corresponding 
aligned residue positions of the query and match (“Sbjct”) are displayed flanking the 
alignment. 
10. Click on the link beginning “pdb” next to “Sequence ID” in the HSP report to access the 
corresponding protein structure information, linking to the PDB structure file. 
11. The query sequence is also searched against the CDD [24] with the graphical output 
arranged above the distribution report (top frame, Fig. 3c). This displays CDD matches 
and also strong matches from the SMART and PFAM databases (see section 3.1.2). Click 
on the CDD output image to open a new browser window with the same graphical display 
and an additional detailed list of matched domains (lower panel, Fig. 3c), detailing the 
boundary regions of the query that matches the domain (“interval”) and E-value match 
significance (see Note 6). 
12. Position the mouse pointer over the domain image in the CDD graphical output, whereby 
a popup window appears with available biological information (right side window in top 
frame, Fig. 3c). Alternatively, click on the “+” of a domain in the list to expand the list to 
provide biological descriptions, with an alignment of the query sequence against the 
consensus for this domain (lower panel, Fig. 3c), with the boundaries shown flanking the 
alignment. Minimize the expansion by clicking “-“. 
 
The results from CDD analyses help identify and define domain boundaries (contributing to 
step A of DBA, Fig. 1), with BLASTP searches identifying close structural homologues (A, 
Fig. 1). CDD and HSP local sequence alignments help to identify consensus residue positions 
that might indicate domain boundaries (steps A and C, Fig. 1). 
 
[Fig 3 near here] 
 
3.1.2 Domain Prediction with HMM Databases: SMART and PFAM 
1. Navigate to the SMART webserver (http://smart.embl-heidelberg.de) [25]. 
2. At the top of the web interface, ensure the SMART mode is set to “NORMAL” and the 
webpage displays a query box. If not, click on the “NORMAL” link in the “SMART 
mode” box. Paste the full-length protein sequence into the query box, ensuring all search 
options are selected in the Sequence Analysis pane (see Note 7). 
3. Run the analysis by selecting the “Sequence SMART” button. 
4. SMART output displays a graphical representation of recognized domains from the 
SMART database, with an approximate residue scale bar (Fig. 4a). Mouse over the 
domain representation to pop-up the residue positions and significance of the match (Fig. 
4a). 
5. If search options were selected (this section, point 2) domains not present in SMART 
may be recognized e.g., PFAM and transmembrane (TM) regions (Fig. 4b, see Note 8). 
6. Click the domain in the graphical output to link to detailed domain information (Fig. 4c). 
7. Click on the “Align your sequence against the SMART alignment” button, to generate a 
similar alignment to the consensus sequence as performed with the CDD software 
(section 3.1.1, point 12). 
 
Results from SMART/PFAM searches may identify both characterized and predicted (DUF) 
domains, with consensus alignments helping delineate domain boundaries (steps A and C, 
Fig. 1), similar but often more sensitive than CDD (section 3.1.1). In addition 
SMART/PFAM also predict low-complexity sequences (often disordered, section 3.2), used 
in step B (Fig. 1), (see Note 9). 
 
[Fig 4 near here] 
 
3.1.3 The PSIPRED Workbench for Protein Domain and Secondary Structure Prediction 
PSIPRED [27] and pGenTHREADER [29, 30] are part of the UCL PSIPRED suite of tools 
[31], for protein fold and secondary structure prediction (http://bioinf.cs.ucl.ac.uk/psipred/) 
(see Note 10). The advantage of this server is that multiple algorithms may be run 
simultaneously from a single query sequence submission. PSIPRED is amongst the most 
accurate predictors of protein secondary structural elements, critical for the DBA procedure 
described here, and in more detail in section 3.3. Like BLAST searches of the PDB database 
(section 3.1.1.), pGenTHREADER is particularly useful to find PDB templates for structural 
considerations in DBA (section 3.3), but has the advantage of using PSI-BLAST and 
threading methods to help determine remote structural homologies (see Note 11) [32], 
increasing sensitivity compared with BLAST in our hands. 
 
1. In the web interface, select PSIPRED and pGenTHREADER and paste the protein 
sequence into the “Input Sequence” window as FASTA or raw sequence format (see Note 
12). Multiple sequences may also be posted. 
2. Enter a valid email address in “Submission Details” pane (recommended, see Note 13) 
and click “Predict” to run the analysis. 
3. Once the submission is complete, the results page (Fig. 5a) displays results from different 
algorithms in different tabs, with the option to download the results (see respective tab) as 
text or printable PostScipt/PDF files. 
4. For pGenTHREADER, click on the respective tab, bringing up a hierarchical display of 
homologous sequence hits relating to the query sequence (see Note 14). Click the links 
under SCOP/CATH codes, CATH entry or on the structure image itself to link to 
structural information from the SCOP [33], CATH [34] or PDBsum [35] databases. 
5. Select the link under “View Alignment” to open a window displaying a structural 
alignment of the query sequence to the respective match (Fig. 5b and see Note 15). 
6. The pGenTHREADER uses a PSIPRED secondary structure prediction in its operation, 
and full results can be seen or downloaded from the respective results tab (Fig. 5a). 
7. Raw PSIPRED results (Fig. 5c) give a useful graphical superimposition of secondary 
structural elements on the protein sequence, with a degree of confidence (blue bars). 
These secondary elements will determine the exact construct boundaries in the DBA 
process, described in section 3.3. 
8. As there is a threshold for query sequence length in PSIPRED, multiple overlapping 
analyses should be performed where appropriate (see Note 12). 
 
pGenTHREADER matches thus help identify homologous domains (step A, Fig.1) and along 
with resulting PSIPRED predictions, help identify secondary structural elements and fine 
domain boundaries (steps C and D respectively, Fig. 1). 
 
 
[Fig 5 near here] 
 
3.2 Protein Domain Identification using Globularity and Disorder Prediction 
The methods described for domain identification have so far been based on prior 
experimental data, often as a consequence of advances in genome sequencing and structural 
genomics. That is, identifying protein domains using previously identified related or 
homologous domains using HMM or alignments, or from structural homology to previously 
solved structures of proteins. However, in order to delineate domains which lack well-defined 
annotation in the literature, unbiased techniques are required. It is well known that protein 
domains are usually made up of globular well-ordered cores of secondary structure, with 
inter-domain linkers often disordered [36]. Here we describe the use of the FoldIndex [37] 
and GlobPlot 2 [38] webservers which provide complementary approaches to predict order 
(globularity) to define domain boundaries and regions of proteins that may negatively 
influence protein crystallization. 
 
3.2.1 Disorder Analysis with FoldIndex 
1. Paste the protein sequence directly into the “Sequence area” window of the FoldIndex 
webserver (http://bioportal.weizmann.ac.il/fldbin/findex) [37]. 
2. Default parameters are advised for the sequence window and step, but enable the “graph 
Phobic values” and “graph charge values” options (see Note 16). 
3. Select the “Process” button to run the analysis. 
4. Predicted folded (ordered, green) and unfolded (disordered, red) regions are graphically 
displayed, mapped to residue position (Fig. 6a), alongside hydrophobic or charged 
regions if previously selected. This image may be saved as a PNG file. 
5. Alongside prediction statistics, (dis)order predictions are mapped onto the primary 
sequence in the output window (Fig. 6b), allowing (dis)order to be mapped onto the 
sequence (see Note 16). 
 
3.2.2 Disorder Analysis with GlobPlot 
1. Paste the protein sequence directly into the “Sequence” window of the GlobPlot 2 
webserver (http://globplot.embl.de) [38]. 
2. Default parameters are advised, but otherwise enable the “Russell/Linding” disorder 
propensity option and the “Perform SMART/Pfam domain prediction” options (see Note 
17). 
3. Select the “GlobPlot NOW!” button to run the analysis. 
4. As with FoldIndex (section 3.2.1), ordered/disordered regions are mapped onto the 
protein primary sequence (Fig. 6c), in this case green/black respectively (see Note 18). In 
addition, predicted ordered sequences (‘GlobDoms”) are listed above the sequence. 
5. Graphical results (which can also be downloaded in PostScript format) display predicted 
globularity/disorder as green/blue blocks respectively, alongside residue number (Fig. 
6d). Disorder propensity is plotted as a white line, with downhill and uphill regions 
corresponding to predicted globular regions or disorder, respectively. 
6. Predicted SMART/PFAM domains are superimposed onto this plot according to the 
included key, allowing simple combination of de novo globularity and HMM approaches. 
FoldIndex and GlobPlot approaches thus help identify globular regions, towards identification 
of (sub)-domains (step A, Fig. 1) and disordered termini (step B, Fig. 1), in the domain 
boundary analysis hierarchy. 
 
[Fig 6 near here] 
 
3.3 Combining Bioinformatics Approaches for Domain Boundary Prediction 
Once bioinformatics analyses have been completed, results should be combined cohesively as 
part of the DBA process. Figure 1 demonstrates the overall DBA workflow, and the 
contribution of each bioinformatics tool to the process. Most aspects of the procedure have 
been duplicated with multiple algorithms, increasing the accuracy of domain boundary 
prediction. Important considerations are illustrated using human POLQ (DNA polymerase θ, 
UniProt ID: O75417) as an example (Fig. 7) [39]. 
 
1. Alignment and HMM-based approaches identify predicted domains by homology (A, Fig. 
1), with improved confidence conferred if multiple servers predict domains in the same 
sequence neighborhood (e.g., PFAM:DEAD and SMART:DEXDc domains, Fig. 7a). 
Additional non-HMM domains (e.g., “BLAST”, Fig. 7a) should also be taken into 
account, even if only found by a single algorithm. Low-complexity sequences are found 
at the extreme ends of the 1-900aa region and are recommended not to be included in 
designed constructs (B, Fig. 1). In this example, the analysis suggests 2-3 domains in 
POLQ from ~80 to 550 residues. 
2. Disorder prediction with both GlobPlot2 and FoldIndex suggests the protein is 
predominantly globular up to 900aa (step A, Fig. 1 and Fig. 6). Biologically inferred data 
from the most homologous structure (Archaeoglobus fulgidus HEL308, found from both 
BLAST searches to the PDB database and pGenTHREADER), suggests that the entire 
region from ~70-850aa is globular from its expression and structural determination, hence 
the HMM-derived domains such as SMART:DEXDc are likely to be sub-domains (A, 
Fig. 1) (see Note 19). 
3. Domain boundaries can in principle focus on the sub-domains, but examination of 
homologous structures (Fig. 7b) suggest that if this was the case, significant biological 
information would be lost (see Note 20). Here, the expected substrate (an ATP analogue) 
is bound between the RecA sub-domains (green/yellow) corresponding to the two 
predicted PFAM/SMART sub-domains in Fig. 7a. Hence, the more biologically relevant 
domain boundaries should span these two sub-domains. Furthermore, a cryptic domain 
not detected in HMM-based searches can only be noted by comparison to the homologous 
HEL308 structure, seen here in the final POLQ structure (helix-hairpin-helix, red in Fig. 
7b). Hence, analysis of sequence similarity in homologous protein structures can yield 
important information in addition to sequence-based HMM searches (step A, Fig. 1). 
4. Co-localization of domains to the same region of sequence may have different local 
boundaries (e.g., PFAM:DEAD 93-274aa and SMART:DEXDc 88-299aa). In such cases 
we recommend using the longer of the two regions if within 10-20 residues as the 
boundary (see Note 9). 
5. Once approximate domain boundaries are predicted, use PSIPRED secondary structure 
predictions to delineate secondary elements as the next level of construct boundary, 
serially expanding the boundaries in both directions one element at a time (step C, Fig. 
1). It is important to compare PSIPRED predictions to the actual elements in homologous 
determined structures e.g., with the structural alignment output of pGenTHREADER (see 
Note 21), to avoid bisecting secondary structural elements. 
 
[Fig 7 near here] 
 
6. If homologous structures are found from BLAST or pGenTHREADER searches, 
PSIPRED secondary element predictions should be compared to those in the known 
structure in case removing a specific element destabilizes the protein (see Notes 22, 23). 
7. The final stage of DBA is to choose the residue positions to determine the precise 
construct boundaries (step D, Fig. 1). It is critical that full secondary elements are 
considered when determining the termini of boundaries, e.g., in this example the first α-
helix as a boundary should begin at GRCLK (Fig. 5c). If resources allow, a further 
boundary should be designed by addition of a small amount of coil/non-element structure, 
e.g., GLGRCLK (Fig. 5c). Close additional boundaries may be useful, as such regions are 
often not structured in crystals and the true secondary element may in fact comprise this 
additional sequence, amongst other factors (see Note 24). 
 
[Fig 8 near here] 
 
3.4 Further Methods for Domain Boundary Analysis: Beyond Bioinformatics 
The DBA approach we have outlined here to delineate protein domains, is designed to be 
used in conjunction with high-throughput parallel cloning and expression methods, as 
described earlier [1]. E. coli systems are predominantly used in initial expression screening, 
moving to baculovirus-mediated insect cell expression if not successful. Although such 
approaches frequently lead to respectable success rates in small scale tests (Fig. 8) [1], re-
iteration of the DBA procedure may be required for protein expression optimization for 
difficult targets. Analogous approaches have been attempted by others, often bringing 
together similar bioinformatics approaches but in automated pipelines, such as ProteinCCD 
[19], or by our colleagues at the Structural Genomics Consortium [6]. However for small-
scale domain prediction, the use of individual bioinformatics tools allows the user a great deal 
of analytical flexibility, depending on the protein in question. 
 
A range of experimental data may also be applied to protein domain delineation. If full length 
protein is available, limited proteolysis combined with mass spectrometric (MS) approaches 
can determine core folded domains, as connecting unfolded sequence or disordered termini 
may be trimmed away by proteases, with core domains identified by MS [40]. In addition, the 
advent of powerful high-throughput screening of random or combinatorial protein truncation 
or mutation libraries allows an unbiased approach with no prior knowledge required [41]. 
Rather than replacing bioinformatics approaches to domain boundary analysis, these 
experimental techniques may facilitate the accuracy of domain prediction for difficult 
proteins, especially if used in combination with in silico approaches described here. 
 
4 Notes 
1. Single or lists of multiple sequences can also be entered in this manner. Sub-sequences 
may be selected in the “Query subrange” box. 
2. The full NCBI protein sequence database can be searched instead if homologous 
structures are not required or found, by selecting the “Non-redundant protein 
sequences(nr)” dropdown option. 
3. We normally leave the “Organism” option blank, to give the greatest chance of finding a 
close homologue. 
4. blastp algorithm parameters can be changed if using protein sequences with few close 
homologues, but we find default parameters are adequate for most sequences, especially 
for mammalian proteins. 
5. HSP (High-scoring Segment Pair) is the alignment of the query to database sequence, 
generally representing a single domain. However multiple HSPs may be present within a 
domain if variable intervening sequences are present (e.g., loop regions or low-
complexity sequences). Significance of matches (“Expect” or “E-value”) is greater the 
smaller the number, with zero being most significant. The length of the match (both for 
identity and similarity (“positives”) is also displayed. 
6. Expect (E)-values are an estimate of the significance of a BLAST match i.e. the number 
of hits expected by chance in a particular database. Hence, the lower the number and 
closer to zero the E-value, the more significant the match e.g., 1e-6 is a good starting point 
for a significant hit. 
7. Optional tick boxes engage additional database searching, including PFAM [26], 
membrane protein signal sequences [42], repeats and outlier homologues. 
8. Identification of TM regions is beneficial, as following their high hydrophobicity, their 
removal increases the likelihood of soluble protein domain expression. 
9. IMPORTANT: CDD/SMART/PFAM methods and domain definitions are very 
conservative, often defining domains as core regions and hence removing surrounding 
regions that may in fact be true domain boundaries. Hence, if multiple methods coincide 
with approximate boundaries, the longest prediction should be used. Furthermore, 
predicted secondary structural elements (section 3.1.3) around these predicted domain 
boundaries should extend away from, rather than into these regions, in order to prevent 
shortened and therefore erroneous domain boundary predictions. 
10. Additional software, useful for construct design and run simultaneously, are available in 
the PSIPRED workbench package [31], particularly for transmembrane helix and 
topology prediction (e.g., MEMSAT3/MEMSATSVM) and additional orthogonal 
disorder prediction (DISOPRED3), but out of the scope of these protocols. 
11. Although pGenTHREADER is useful for detecting remote structural homologies in the 
case of low sequence similarity, care should be taken in the interpretation of, or using 
such remote homologies, as false positive hits may be prevalent with some hits bearing no 
real functional similarity. 
12. An upper sequence length limit of 1500 residues exists for PSIPRED workbench servers. 
Hence longer proteins should be broken down into shorter fragments for submission, 
ideally not comprising multiple domains. These should be arranged to tile of fragment 
predictions with 200-500 residue overlaps, to ensure that positioning at fragment ends 
does not influence prediction accuracy. 
13. The PSIPRED workbench algorithms are computationally intensive and may take up to 
two hours to run, hence it is recommended to supply an email address for delivery of a 
weblink to results. 
14. The color code on the left panel for pGenTHREADER results (Fig. 5a) gives a rapid idea 
of match confidence, with green being firm hits, followed by orange then yellow (weak). 
Orange/weak hits should only be used if green and confident matches are not found, 
suggesting only remote structural homology has been found. 
15. pGenTHREADER structural alignments are especially useful when only remote 
homologies are matched to query sequences, guiding alignment on the basis of 
(predicted) structure, rather than potentially biased or misguided poor sequence 
similarity. In such circumstances, the use of multiple weak/average matches should be 
used to reduce bias in PDB template choice. 
16. Graphing the hydrophobic and charged regions in FoldIndex gives further information to 
solubility propensity i.e. hydrophobic/charged regions are likely to negatively/positively 
influence protein solubility respectively. 
17. The SMART/PFAM search is useful in GlobPlot, superimposing HMM-based domain 
searches (section 3.1.2) onto globularity/disorder predictions and the query sequence. 
18. Copying the colored alignment from FoldIndex and GlobPlot and pasting into word 
processing or text editing software with the “Courier” font preserves text formatting and 
spacing for useful documentation. 
19. It should be noted that although a stretch of protein may be predicted to be (globally) 
globular, it could in fact comprise a string of local globular domains with very small 
linkers that do not show up in disorder prediction. 
20. Many protein structure visualization platforms may be freely downloaded, and although 
this is out of the scope of this chapter, the authors recommend Chimera 
(cgl.ucsf.edu/chimera/) [43] or PyMOL (pymol.org). 
21. If only remote homologues exist, such structural alignments in pGenTHREADER will 
considerably increase the accuracy of secondary element prediction. 
22. Removing specific secondary structural elements could expose significant regions of 
hydrophobicity (or remove favorable charged regions), both of which could diminish 
protein solubility. 
23. In parallel β-sheets in particular, the strand arrangement from one side to another does not 
necessarily follow the N- to C-terminal order. Hence, removal of the most N-terminal 
strand could destabilize a whole β-sheet if juxtaposed centrally in the β-sheet, with 
increased likelihood of protein insolubility (e.g., removal of N-terminal β1 or β2 in a 
POLQ would split the β-sheet, Fig. 7c). 
24. Terminal residue composition may influence protein expression [44], hence a range of 
alternative but close boundaries may be beneficial. Even if soluble protein is produced, 
some terminal residues may negatively influence crystal packing, e.g., PPPGLGRCLK 
(Fig. 5c) may cause a sharp N-terminal kink increasing disorder or decrease potential 
packing, due to the high proline content. 
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Figure Captions 
Fig. 1. Representation of the hierarchical approach to domain boundary analysis. The 
workflow is shown by boxed rectangles (A to D) connected by solid black arrows. The 
involvement of bioinformatics tools at various pipeline stages (dark gray boxes, grouped by 
type of method (rounded light gray boxes)), is represented by grey arrows. Dashed gray 
arrows represent iteration of secondary element/fine boundary redesign following cloning and 
protein test expression, where necessary. Abbreviations: p-HMM, profile-Hidden Markov 
Model; MSA, Multiple Sequence Alignment; PDB, Protein Data Bank. 
 
Fig. 2. Representation of domain boundary analysis. Individual domains in a full-length 
protein sequence are identified (blue/orange), then combinatorial sets of N- and C-terminal 
truncations are made. Constructs containing tandem domains (red) may also be used. 
 
Fig. 3. Screenshot from NCBI BLAST output using the human POLQ protein as input to 
search against the PDB database. (a) Distribution of BLAST hits mapped onto the input 
sequence, color coded for strength of alignment. (b) Detailed BLAST HSP alignment. (c) 
CDD output (top frames, domain annotations with example pop up window for cd06140 CDD 
entry; lower frames, domain lists with example expansion showing input sequence alignment 
against CDD consensus). 
 
Fig. 4. Screenshot from SMART output, using human POLQ protein as input. (a) Graphical 
output showing recognized SMART domain, with popup window on mouse over. (b) 
Graphical output showing recognized transmembrane region (blue) and PFAM domain, with 
popup window on mouse-over. (c) Expansion on clicking SMART domain from Fig. 4(a). 
 
Fig. 5. Screenshots of graphical outputs from the PSIPRED suite of programs. (a) 
pGenTHREADER table output, with most identical/homologous sequence ranked highest 
(lowest p-value is most significant), with high confidence hits in green (medium in orange 
and weak in red, not shown). (b) Structural alignment output following selection of “View 
Alignment” in (a). Predicted or structurally determined α-helices (purple) and β-strands 
(yellow) are mapped onto query and matched sequences, respectively. (c) Detailed PSIPRED 
output for query sequence with same color scheme as for (b), with secondary elements 
definitions: C, coil, H, α-helix, E, β-strands, and “Conf” representing prediction confidence. 
 
Fig. 6. Output from FoldIndex and GlotPlot servers, using residues 1-1500 or full length 
human POLQ as a query sequence, respectively. (a) FoldIndex PNG file graphical output, 
with green and red regions as folded/unfolded respectively. Hydrophobic and charge 
propensity are plotted as blue and pink traces respectively. (b) FoldIndex output screenshot 
with predicted ordered/disordered regions plotted onto the query sequence as green/red text 
respectively. (c) GlobPlot output screenshot with predicted globular/disordered regions 
plotted onto the query sequence as green capitalized/black small case text respectively. (d) 
GlobPlot graphical output for full-length POLQ as query sequence. Globular domains are 
green blocks, disordered regions as blue blocks and recognized SMART domains according 
to the key. Disorder propensity is plotted as the white line, described in the main text. 
 Fig. 7. Considerations in domain boundary analysis. (a) Representation of PFAM and 
SMART detected domains mapped to the first 1000 residues of human POLQ (base image 
generated by SMART server [25]). Numbers in parentheses denotes predicted domain 
boundaries from respective analyses, with low-complexity regions in purple. The closest 
structure homologue is PDB:2P6R A. fulgidus HEL308. (b) (Sub) domain crystallized 
structure of human POLQ (~residues 70-900, PDB:5AGA [39]), showing RecA and helix-
hairpin-helix subdomains rendered in green/yellow and red, respectively. (c) Parallel β-sheet 
from human POLQ structure showing non-contiguous β-strand arrangement, with strands 
numbered from N- to C-terminus (β1 to β7). Images in (b) and (c) were rendered with 
Chimera [43]. 
 
Fig. 8. Typical small-scale protein expression screening. SDS-PAGE analysis of 3ml test 
expression from Sf9 insect cell of various N- and C-terminal construct truncations of human 
POLQ, following no soluble expression in E. coli. Red arrows denote successful and 
correctly-sized proteins. 
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